Sjs Investment Consulting Inc. Bristol Myers Squibb CO Transaction History
Sjs Investment Consulting Inc.
- $540 Million
- Q4 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 1,052 shares of BMY stock, worth $62,772. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,052
Previous 1,005
4.68%
Holding current value
$62,772
Previous $52,000
13.46%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding BMY
# of Institutions
2,568Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11.3 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.47 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.54 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.65 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.64 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $127B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...